Clinical Trial Update: Etomidate vs. Midazolam for Sedation During ERCP [Phase 4]

View source ↗

Summary

Phase 4 trial comparing etomidate to midazolam for sedation during ERCP; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Choledocholithiasis
• Pancreatic Cancer
• Pancreatitis

Drugs mentioned

• Etomidate (etomidate)
• Midazolam (Midazolam)

Snippet

Sponsor: Cheju Halla General Hospital | Conditions: Choledocholithiasis, Cholangiocarcinoma | Phase 4 | Status: COMPLETED | Results posted: 2015-06-29